Exogenous group G Streptococcus endophthalmitis following intravitreal ranibizumab injection

References

• BrownDMRegilloCDAnti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patientsAm J Ophthalmol2007144462763717893015
   PubMed Web of Science ®Google Scholar
• AndreoliCMMillerJWAnti-vascular endothelial growth factor therapy for ocular neovascular diseaseCurr Opin Ophthalmol200718650250818163003
   PubMed Web of Science ®Google Scholar
• RosenfeldPJBrownDMHeierJSRanibizumab for neovascular age-related macular degenerationN Engl J Med2006355141419143117021318
   PubMed Web of Science ®Google Scholar
• BrownDMMichelsMKaiserPKHeierJSSyJPIanchulevTANCHOR Study GroupRanibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR studyOphthalmology20091161576519118696
   PubMed Web of Science ®Google Scholar
• RegilloCDBrownDMAbrahamPRandomized, double-masked, sham-controlled trial of Ranibizumab for neovascular age-related macular degeneration: PIER Study year 1Am J Ophthalmol2008145223924818222192
   PubMed Web of Science ®Google Scholar
• BoyerDSHeierJSBrownDMFrancomSFIanchulevTRubioRGA phase IIIb study to evaluate the safety of ranibizumab in subject with neovascular age-related macular degenerationOphthalmology200911691731173919643495
   PubMed Web of Science ®Google Scholar
• ChhatwalGSMcmillanDJTalaySRPathogenicity factors in group C and G streptococciFischettiVAGram-Positive Pathogens2nd editionWashington, DCASM Press2006213221
   Google Scholar
• AuckenthalerRHermansPEWashingtonJA2ndGroup G streptococcal bacteremia: clinical study and review of the literatureRev Infect Dis1983521962046844802
   PubMedGoogle Scholar
• GohESLiewGCTraumatic bleb-associated Group-G beta-haemolytic Streptococcus endophthalmitisClin Experiment Ophthalmol200836658058118954323
   PubMed Web of Science ®Google Scholar
• SuemoriSSawadaAKamoriSMochizukiKOhkusuKTakemuraHCase of endogenous endophthalmitis caused by Streptococcus equisimilisClin Ophthalmol201019491791820823933
   PubMedGoogle Scholar
• FitnakDRShahGKBlinderKJIncidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumabRetina200828101395139918827737
   PubMed Web of Science ®Google Scholar
• BhavsarARGoogeJMJrStockdaleCRRisk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab- triamcinolone clinical trialsArch Ophthalmol2009127121581158320008710
   PubMedGoogle Scholar
• FongDSCustisPHowesJHsuJWIntravitreal bevacizumab and ranibizumab for age-related macular degeneration a multicenter, retrospective studyOphthalmology2010117229830219969368
   PubMed Web of Science ®Google Scholar
• SpeakerMGMenikoffJAProphylaxis of endophthalmitis with topical povidone-iodineOphthalmology19919812176917751775308
   PubMed Web of Science ®Google Scholar
• AielloLPBruckerAJChangSEvolving guidelines for intravitreous injectionsRetina200424Suppl 5S3S1915483476
   PubMed Web of Science ®Google Scholar
• WooSJHanJMAhnJBilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillanceRetina201232466767122307220
   PubMed Web of Science ®Google Scholar
• MahajanVBElkinsKARussellSRBilateral intravitreal injection of antivascular endothelial growth factor therapyRetina2011311313521187731
   PubMed Web of Science ®Google Scholar
• DavisRPScheflerACMurrayTGConcomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degenerationClin Ophthalmol2010470370720689785
   PubMedGoogle Scholar
• SylvetskyNRavehDSchlesingerYRudenskyBYinnonAMBacteremia due to beta-hemolytic Streptococcus group G: increasing incidence and clinical characteristics of patientsAm J Med2002112862262612034411
   PubMed Web of Science ®Google Scholar
• WickramasingheNHarrisKBilateral endophthalmitis as a primary manifestation of Streptococcus dysgalactiae endocarditis and the role of 16S rDNA polymerase chain reaction in identificationDiagn Microbiol Infect Dis201067218518720338706
   PubMed Web of Science ®Google Scholar
• GopalamuruganABWheatcroftSHunterPThomasMRBilateral endophthalmitis and ARDS complicating group G streptococcal endocarditisLancet20053669502206216338455
   PubMed Web of Science ®Google Scholar
• VerweijPERademakersAJKoopmansPPMeisJFEndophthalmitis as presenting symptom of group G streptococcal endocarditisInfection199422156578181845
   PubMed Web of Science ®Google Scholar
• ZiakasNGTzetziDBoboridisKGeorgiadisNSEndogenous group G Streptococcus endophthalmitis following a dental procedureEur J Ophthalmol2004141596015005587
   PubMed Web of Science ®Google Scholar
• SongAScottIUFlynnHWJrBudenzDLDelayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomesOphthalmology2002109598599111986108
   PubMed Web of Science ®Google Scholar
• FarberBPWeinbaumDLDummerJSMetastatic bacterial endophthalmitisArch Intern Med1985145162643970649
   PubMedGoogle Scholar
• MillerKMGlasgowBJBacterial endophthalmitis following sutureless cataract surgeryArch Ophthalmol199311133773798447751
   PubMedGoogle Scholar
• RitterbandDCShahMKBuxtonDJIntalMCGutherieDSSeedorJAA devastating ocular pathogen: beta-streptococcus Group GCornea200019329730010832687
   PubMed Web of Science ®Google Scholar
• RogersNKFoxPDNobleBAKerrKInglisTAggressive management of an epidemic of chronic pseudophakic endophthalmitis: results and literature surveyBr J Ophthalmol19947821151198123618
   PubMed Web of Science ®Google Scholar
• MaaloufFAbdulaalMHamamRNChronic postoperative endophthalmitis: a review of clinical characteristics, microbiology, treatment strategies, and outcomesInt J Inflam2012Article ID 313248
   Google Scholar